StockDriftsStockDriftsTop 6 Gilead Sciences, Inc. Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| ACLX | Arcellx Inc | 36.44% | 6.72M | $771.7M | +0.00%(+0) | $80.10(+43.66%) | 2026-03-31 | |
| RCUS | Arcus Biosciences Inc | 32.05% | 31.42M | $678.8M | +0.00%(+0) | $14.93(+103.17%) | 2026-03-31 | |
| GLPG | Galapagos NV | 23.67% | 16.71M | $501.2M | +0.00%(+0) | $28.15(+4.81%) | 2026-03-31 | |
| ASMB | Assembly Biosciences Inc | 5.9% | 4.51M | $125.0M | +0.00%(+0) | $18.72(+48.17%) | 2026-03-31 | |
| KYTX | Kyverna Therapeutics Inc | 1.68% | 4.13M | $35.6M | +0.00%(+0) | $4.31(+106.03%) | 2026-03-31 | |
| XLO | Xilio Therapeutics Inc | 0.26% | 650.4K | $5.5M | -92.86%(-8.46M) | $12.20(-25.01%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +23.12% | +86.62% |
| Top 20 Holdings Unweighted | +36.27% | +153.06% |
Sign up free to track Gilead Sciences, Inc., compare funds side by side, and get alerts the moment positions change.